A New Jersey pharmaceutical company has recalled high blood pressure medication because the pills may be contaminated with metal, according to an alert it issued this week.
Breckenridge Pharmaceutical, Inc. has recalled one lot of the 60-milligram Propranolol Hydrochloride Extended-Release Capsules. The medication, manufactured by Philadelphia-based Adare Pharma Solutions, was distributed nationwide to wholesalers and pharmacies by Breckenridge Pharmaceutical between Oct. 26 and Nov. 4.
Those who use the product could suffer soft-tissue lacerations in the oral cavity, esophagus, stomach or intestine, Breckenridge Pharmaceutical said. As of this week, there haven’t been any reports of injuries or adverse effects related to the products.
According
to Breckenridge Pharmaceutical, the recalled lot contains the same batch of ingredients the company believes led to metal contamination in a different lot.
USA TODAY contacted Breckenridge Pharmaceutical and Adare Pharma Solutions on Nov. 17 for further comment, including where the affected medications were sold.
The recall follows another New Jersey company, Advagen Pharma Limited, which recalled 3,684 bottles of 50-milligram metoprolol tartrate tablets in late October because they may have contained foreign tablets or capsules.
Another company, Macleods Pharmaceuticals, recalled some of its tablets on Oct. 7 for "failed dissolution specifications," noting that the drug does not release active ingredients properly inside the body, causing it to be ineffective in treating high blood pressure.
Here’s what we know about the latest Breckenridge Pharmaceutical recall.
How do I know if I have the recalled medication?
The company has recalled the product labeled Propranolol Hydrochloride Extended-Release Capsules. The 60-milligram pills are sold in 100-count bottles with an expiration date of May 2029.
The national drug code (NDC) is 51991-817-01, and the recalled lot no. is PK25110035.
What should I do?
Customers who have the medication from lot no. PK25110035 should immediately stop taking it and contact their doctors for medical advice and replacement instructions, Breckenridge Pharmaceutical said. Consumers can return any unused portion of the pills to the pharmacy where they bought them.
Those who have experienced problems related to the drug should contact their doctors, Breckenridge Pharmaceutical said.
Wholesalers, pharmacies and other retailers have been instructed to check their inventories for the recalled lot, quarantine any affected product and stop distributing it.
Who can I contact for help?
Customers with questions can contact Breckenridge Pharmaceutical’s recall service provider, Qualanex, at 1-855-736-0807 from 9 a.m. to 5 p.m. E.T., Monday through Friday. They can also email recall@qualanex.com.
To report adverse reactions or quality problems, individuals can contact the U.S. Food and Drug Administration’s MedWatch Adverse Event Reporting program by:
- Submitting information online at www.fda.gov/medwatch/report.htm.
- Downloading the reporting form at www.fda.gov/MedWatch/getforms.htm or calling 1-800-332-1088 to request a form, then completing and returning the form to the address provided or faxing it to 1-800-FDA-0178.
Contributing: Mary Walrath-Holdridge, USA TODAY
Saleen Martin is a reporter on USA TODAY’s trending team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@usatoday.com.
This article originally appeared on USA TODAY: Blood pressure medication recalled nationwide. See affected drug













